Title:
PHARMACEUTICAL COMPOSITION FOR ADENOVIRAL CONJUNCTIVITIS
Document Type and Number:
WIPO Patent Application WO/2021/210070
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a pharmaceutical composition effective for adenoviral conjunctivitis. Provided is a pharmaceutical composition for adenoviral conjunctivitis, containing an anti-adenovirus polyclonal antibody. The pharmaceutical composition is an ophthalmic solution. The pharmaceutical composition can be used for the treatment of adenoviral conjunctivitis. The pharmaceutical composition can be used for the prevention of adenoviral conjunctivitis in an uninfected eye.
More Like This:
Inventors:
OKUDA KENJI (JP)
SHIMADA MASARU (JP)
SHIMADA MASARU (JP)
Application Number:
PCT/JP2020/016447
Publication Date:
October 21, 2021
Filing Date:
April 14, 2020
Export Citation:
Assignee:
OKUDA KENJI (JP)
MIZUKI NOBUHISA (JP)
SHIMADA MASARU (JP)
MIZUKI NOBUHISA (JP)
SHIMADA MASARU (JP)
International Classes:
A61P27/02; A61K39/395
Foreign References:
| JP2012526075A | 2012-10-25 |
Other References:
YOKOTA, TOMOYUKI: "An Immunoepidemiological Study of Neutralizing Antibody against Adenovirus Type-3 in Children of Primary Schools Which had Experienced Outbreaks of Pharyngoconjunctival Fever", JOURNAL OF JAPANESE ASSOCIATION FOR INFECTIOUS DISEASES, vol. 41, 1968, pages 245 - 251
KITAICHI, NOBUYOSHI ET AL.: "The evaluation of a newly developed rapid diagnosis kit of human adenovirus by immunochromatography labeled platinum-gold colloids", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 237, no. 2, 2011, pages 210 - 214
KITAICHI, NOBUYOSHI ET AL.: "The evaluation of a newly developed rapid diagnosis kit of human adenovirus by immunochromatography labeled platinum-gold colloids", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 237, no. 2, 2011, pages 210 - 214
Attorney, Agent or Firm:
NAKAMURA Kazuo (JP)
Download PDF: